Calculate concentration and sample volumes for neutral laboratory research workflows.
The linked sources lead to PubMed and open in a new tab.
Scientific profile
PT-141 in the peptide lexicon: mechanism, evidence and sources
Companion tool
See how long PT-141 stays in your system
Model mass and liquid-volume relationships for a 10 mg PT-141 research vial using study-defined or laboratory-defined inputs.
The calculation reports arithmetic for research documentation. It does not transfer instructions from Vyleesi or any finished medicine to this vial.
The output is not a human dose, injection protocol, treatment recommendation, or administration schedule.
PT-141, commonly called bremelanotide, is a synthetic cyclic heptapeptide developed from melanocortin peptide research. Its compact seven-amino-acid structure and activity across melanocortin receptor subtypes make it a defined reference material for receptor pharmacology, analytical method development, and other controlled laboratory investigations. This product contains 10 mg of lyophilized PT-141 in a sealed research vial.
The vial is supplied exclusively for research use. It is not a medicine, medical device, compounded preparation, or material intended for administration to people or animals. The 10 mg label describes the nominal research-vial format; it is not a recommended dose and must not be interpreted as clinical guidance.
For research use only. Not for human or veterinary use, diagnosis, treatment, prevention, or consumption. The presence of bremelanotide as the active peptide in an approved medicine does not make this research vial an approved, substitutable, or clinically validated product.
Choose a peptide to open its dedicated calculator page with pre-filled values.
View Product
PT-141Choose a peptide to open its dedicated calculator page with pre-filled values.
